IL1A and Stroke: Acute post-stroke IV or IA IL-1α administration resulted in comparable significant reductions in ischemic infarct volume, fewer apoptotic cells, improved functional recovery, and decreased neuroinflammatory activation, the latter with IA treatment being more effective than IV treatment.